A 6-year-old intact male Doberman Pinscher presents for r...

Thank you for reaching out regarding this 6-year-old intact male Doberman Pinscher. The findings you've described—a Grade 3/6 left apical systolic murmur and frequent ventricular premature contractions (VPCs) on an ECG—are significant in this breed and warrant immediate, thorough investigation. Doberman Pinschers are highly predisposed to an aggressive form of Dilated Cardiomyopathy (DCM), often presenting with an "occult" phase characterized by electrical and/or structural changes before clinical signs of heart failure emerge.

Let's break down the recommended screening, diagnostic protocol, and treatment initiation for this patient.

Recommended Screening and Diagnostic Protocol for Early Detection of DCM in Dobermans

For Doberman Pinschers, annual screening for DCM should ideally begin around 3-4 years of age. A routine physical exam and a single resting ECG are insufficient for comprehensive screening due to the nature of the disease's progression. The gold standard screening protocol includes:

Echocardiogram: A complete echocardiographic examination is crucial to assess cardiac structure and function. Key measurements include:

* Left ventricular internal dimensions in diastole (LVIDd) and systole (LVIDs). These are often normalized to body weight (LVIDdN) to account for size variation.
* Fractional Shortening (FS%) and E-point Septal Separation (EPSS) to assess systolic function.
* Left atrial-to-aortic root ratio (LA:Ao) to evaluate left atrial size.
* Assessment of valve morphology and function, especially the mitral valve, to characterize any regurgitation.
* Early changes in Doberman DCM might include subtle LV dilation, reduced systolic function, or even just mild wall motion abnormalities.

24-hour Holter Monitor: This is paramount for Dobermans. Resting ECGs frequently miss significant arrhythmias, as the VPCs can be intermittent. A 24-hour Holter monitor quantifies the total burden of VPCs and identifies runs of ventricular tachycardia (VT).

* A VPC count exceeding 100/24 hours is considered suspicious for occult DCM in Dobermans.
* A count exceeding 1,000 VPCs/24 hours is a strong indicator of occult DCM and often triggers treatment recommendations.

Applying to Your Patient: Diagnostic Protocol

Given your patient's findings:

* Frequent VPCs on ECG: This is a red flag. A 24-hour Holter monitor is absolutely indicated to quantify the arrhythmia burden. This will help determine if the dog has significant electrical disease.
* Grade 3/6 Left Apical Systolic Murmur: While many Dobermans with occult DCM are initially murmur-free, or develop a mitral regurgitation murmur later in the disease course, this finding requires investigation. The murmur could be secondary to mitral regurgitation from early LV dilation, or it could be a functional murmur.
* A comprehensive echocardiogram is essential to characterize the murmur, confirm or rule out structural heart disease, assess chamber dimensions, and evaluate systolic function. This will help us determine if the dog is in Stage B1 (structural disease without remodeling) or Stage B2 (structural disease with significant remodeling).
* Additional Baseline Diagnostics:
* Systemic Blood Pressure: To rule out hypertension as a contributing factor.
* Routine Bloodwork: Including a complete blood count (CBC), serum biochemistry panel, and thyroid function tests (T4, TSH). While less common in Dobermans, hypothyroidism can sometimes exacerbate cardiac issues. Taurine levels can be considered, especially if there's any history of non-traditional diets, but are not a primary driver of DCM in Dobermans like they are in some other breeds.

When to Initiate Pimobendan

The decision to initiate pimobendan in Dobermans in the occult phase of DCM is driven by strong evidence from the PROTECT trial. This trial demonstrated that starting pimobendan in Dobermans with occult DCM significantly delayed the onset of congestive heart failure (CHF) and prolonged survival.

Based on ACVIM consensus guidelines for DCM, pimobendan should be initiated when a Doberman is diagnosed with Stage B2 DCM. This stage is defined by:

* Structural Heart Disease: Echocardiographic evidence of left ventricular enlargement (e.g., LVIDdN > 1.7) and/or systolic dysfunction (e.g., FS% < 25-30%), even if mild, in the absence of clinical signs of CHF.
* AND/OR Significant Arrhythmias: A high burden of ventricular arrhythmias, typically defined as >1,000 VPCs per 24 hours on a Holter monitor, even if echo changes are minimal or borderline.

Therefore, for your patient:

Once the full echocardiogram and 24-hour Holter monitor are performed, we will be able to accurately stage this dog. If the findings meet the criteria for Stage B2 DCM (either significant structural changes on echo, or a high VPC burden, or both), then pimobendan should be initiated.

The recommended dose for pimobendan is 0.25-0.3 mg/kg PO Every 12 hours. It is crucial to administer pimobendan on an empty stomach, ideally one hour before feeding, as food can reduce its absorption by approximately 30%.

It is important to emphasize that this dog, despite the concerning findings, is currently in a "heart disease" stage, not "heart failure." Therefore, diuretics like furosemide are not indicated at this point and could even be detrimental by activating the renin-angiotensin-aldosterone system (RAAS) without providing clinical benefit.

I would recommend proceeding with the comprehensive echocardiogram and 24-hour Holter monitor as soon as possible to accurately stage this Doberman and formulate an evidence-based treatment plan. Please let me know the results, and we can discuss the next steps.